A problem to be solved by the present invention is to provide a pharmaceutical preparation to be administered to the intranasal mucosa, and in order to solve such a problem, the present invention provides a pharmaceutical preparation to be administered to the intranasal mucosa, in which the pharmaceutical preparation includes a composite particle containing one or more titanium oxide particles, one or more metal particles, and one or more calcium phosphate particles.
